HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vladimir Kepe Selected Research

dicyanmethane (malononitrile)

1/2013Vascular risk and FDDNP-PET influence cognitive performance.
7/2012Self-reported memory impairment and brain PET of amyloid and tau in middle-aged and older adults without dementia.
2/2012Prediction of cognitive decline by positron emission tomography of brain amyloid and tau.
11/2011Protein binding in patients with late-life depression.
6/2011Positron emission tomography of brain β-amyloid and τ levels in adults with Down syndrome.
1/2011The merits of FDDNP-PET imaging in Alzheimer's disease.
3/2010PET of brain prion protein amyloid in Gerstmann-Sträussler-Scheinker disease.
2/2010Movement correction method for human brain PET images: application to quantitative analysis of dynamic 18F-FDDNP scans.
6/2009Depression and anxiety symptoms are associated with cerebral FDDNP-PET binding in middle-aged and older nondemented adults.
5/2009Differential FDDNP PET patterns in nondemented middle-aged and older adults.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Vladimir Kepe Research Topics

Disease

29Alzheimer Disease (Alzheimer's Disease)
01/2014 - 01/2002
10Amyloid Plaque
07/2012 - 01/2002
8Cognitive Dysfunction
01/2014 - 01/2006
8Dementia (Dementias)
01/2013 - 04/2006
5Neurodegenerative Diseases (Neurodegenerative Disease)
11/2017 - 04/2006
4Disease Progression
10/2013 - 03/2010
3Neoplasms (Cancer)
11/2018 - 07/2015
3Tauopathies
11/2017 - 01/2011
2Prostatic Neoplasms (Prostate Cancer)
11/2018 - 07/2015
2Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome)
01/2013 - 04/2006
2Parkinson Disease (Parkinson's Disease)
01/2013 - 04/2006
2Frontotemporal Dementia (Semantic Dementia)
02/2008 - 11/2006
1Hepatocellular Carcinoma (Hepatoma)
11/2019
1Type 2 Diabetes Mellitus (MODY)
07/2018
1Glioblastoma (Glioblastoma Multiforme)
07/2018
1Astrocytoma (Pilocytic Astrocytoma)
07/2018
1Traumatic Brain Injuries (Traumatic Brain Injury)
01/2016
1Adenocarcinoma
07/2015
1Pancreatic Neoplasms (Pancreatic Cancer)
07/2015
1Amyloidosis
10/2013
1Ischemia
02/2013
1Brain Concussion (Cerebral Concussion)
02/2013
1Hypoxia (Hypoxemia)
02/2013
1Stroke (Strokes)
01/2013
1Major Depressive Disorder (Major Depressive Disorders)
11/2011
1Down Syndrome (Down's Syndrome)
06/2011
1Atrophy
01/2011
1Brain Diseases (Brain Disorder)
03/2010
1Pick Disease of the Brain (Pick's Disease)
04/2006
1Cerebral Amyloid Angiopathy (Congophilic Angiopathy)
04/2006
1Prion Diseases (Transmissible Spongiform Encephalopathies)
04/2006
1Multiple System Atrophy
04/2006

Drug/Important Bio-Agent (IBA)

22Amyloid (Amyloid Fibrils)IBA
11/2013 - 05/2005
16dicyanmethane (malononitrile)IBA
01/2013 - 01/2002
82- (1- (6- ((2- fluoroethyl)(methyl)amino)- 2- naphthyl)ethylidene)malononitrileIBA
01/2013 - 01/2002
6Biomarkers (Surrogate Marker)IBA
10/2013 - 01/2007
5Glucose (Dextrose)FDA LinkGeneric
07/2018 - 02/2008
5FluorineIBA
02/2012 - 05/2009
4Amyloid beta-PeptidesIBA
01/2006 - 01/2002
2SodiumIBA
07/2018 - 07/2015
2Sodium-Glucose Transport ProteinsIBA
07/2018 - 07/2015
2methyl-4-fluoro-4-deoxyglucoseIBA
07/2018 - 07/2015
2Sodium-Glucose Transporter 2 InhibitorsIBA
07/2018 - 07/2015
2tau Proteins (tau Protein)IBA
11/2017 - 02/2013
2Amyloidogenic ProteinsIBA
10/2013 - 11/2011
2PrionsIBA
03/2010 - 04/2006
2naphthaleneIBA
04/2006 - 01/2006
22- (1,1- dicyanopropenyl- 2- )- 6- dimethylaminonaphthaleneyIBA
11/2003 - 01/2002
1Clofarabine (Clolar)FDA Link
11/2019
1AndrogensIBA
11/2018
1Dihydrotestosterone (Androstanolone)IBA
11/2018
1Testosterone (Sustanon)FDA Link
11/2018
1Sodium-Glucose Transporter 2IBA
07/2018
1Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
07/2018
1SolutionsIBA
01/2016
1Flavin-Adenine Dinucleotide (FAD)IBA
01/2014
1Prion ProteinsIBA
03/2010
1Molecular Probes (Molecular Probe)IBA
07/2009
1Apolipoprotein E4IBA
01/2009
1VaccinesIBA
02/2008
1Neurotransmitter Agents (Neurotransmitter)IBA
02/2008
1Biological ProductsIBA
01/2008
1Flurbiprofen (Froben)FDA LinkGeneric
01/2008
1ProdrugsIBA
01/2008
1AcidsIBA
01/2008
1ParaffinIBA
04/2006
1Proteins (Proteins, Gene)FDA Link
04/2006
1SolventsIBA
04/2006
1Congo RedIBA
04/2006
1Serotonin (5 Hydroxytryptamine)IBA
01/2006
1benzamideIBA
01/2006
15-HT1A Serotonin ReceptorIBA
01/2006
1Peptides (Polypeptides)IBA
05/2005
1Ibuprofen (Motrin)FDA LinkGeneric
11/2003
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
11/2003
1Naproxen (Naprosyn)FDA LinkGeneric
11/2003
1NaphthalenesIBA
11/2003

Therapy/Procedure

4Therapeutics
11/2018 - 01/2013
2Intravenous Injections
06/2009 - 01/2009
1Castration
11/2018